A phase II study of bortezomib in patients with MALT lymphoma
We have performed a phase II study to evaluate bortezomib in patients with MALT-lymphoma. Sixteen patients entered the trial, 4 had gastric MALT-lymphoma, 7 of the ocular adnexa, one of the colon, and 2 of the parotid, and one patient each the lung and the breast. Bortezomib was given at 1.5 mg/m2 d...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2009-05-01
|
| Col·lecció: | Haematologica |
| Accés en línia: | https://haematologica.org/article/view/5255 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|